Drug intelligence / Profile preview

PIEX

Development stage
Unknown
Lead developer
Becanex
Modality
Small Molecules
Administration
Inhalation
01

Overview

PIEX (Plant-Identical Extracts) is a line of full-spectrum cannabis extracts developed by the German company Becanex GmbH for use as active pharmaceutical ingredients (APIs) in medical therapy. These extracts are produced using a proprietary one-step extraction technology designed to preserve the natural ratio of phytocannabinoids (primarily THC and CBD) and terpenes found in the source cannabis flower. This plant-identical profile is intended to facilitate the "entourage effect," where terpenes modulate the activity of cannabinoids to enhance therapeutic efficacy and reduce side effects. PIEX is available in various formulations, such as PIEX 2 (containing 70% THC), and is intended for individualized cannabis-based medical therapy. While primarily administered sublingually via a dosed pipette, feasibility studies have validated its use for inhalation via medical vaporizers such as the MIGHTY+ MEDIC and VOLCANO MEDIC. It is positioned as a natural alternative to synthetic cannabinoids like dronabinol, offering precise dosing and easier handling due to its honey-like viscosity.

Brand names
PIEX
Other names
Plant-Identical ExtractsPIEX 2PIEX2PIEX-2
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on PIEX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIEX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call